76 related articles for article (PubMed ID: 15506466)
1. [Pathophysiological significance of endothelin in pulmonary hypertension].
Yoshibayashi M
Nihon Rinsho; 2004 Sep; 62 Suppl 9():644-7. PubMed ID: 15506466
[No Abstract] [Full Text] [Related]
2. [Endothelin].
Maeda S; Miyauchi T; Goto K
Nihon Rinsho; 2006 Jul; 64 Suppl 5():112-6. PubMed ID: 16895176
[No Abstract] [Full Text] [Related]
3. Endothelin and endothelin receptor antagonists in systemic rheumatic disease.
Mayes MD
Arthritis Rheum; 2003 May; 48(5):1190-9. PubMed ID: 12746891
[No Abstract] [Full Text] [Related]
4. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.
Hachulla E; Coghlan JG
Ann Rheum Dis; 2004 Sep; 63(9):1009-14. PubMed ID: 15308510
[TBL] [Abstract][Full Text] [Related]
5. [Therapy according to current guidelines. Practical management of pulmonary arterial hypertension.].
Pabst S; Hammerstingl C; Nickenig G; Skowasch D
Pharm Unserer Zeit; 2010 Nov; 39(6):448-52. PubMed ID: 20967933
[No Abstract] [Full Text] [Related]
6. [PAH and many other indications. Old and new endothelin receptor antagonists.].
Schmitz J; Holzgrabe U
Pharm Unserer Zeit; 2010 Nov; 39(6):430-5. PubMed ID: 20967930
[No Abstract] [Full Text] [Related]
7. The endothelin system and its role in pulmonary arterial hypertension (PAH).
Pepke-Zaba J; Morrell NW
Thorax; 2005 Jun; 60(6):443-4. PubMed ID: 15923241
[No Abstract] [Full Text] [Related]
8. [Endothelin].
Kanno K; Hirata Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():581-4. PubMed ID: 16149582
[No Abstract] [Full Text] [Related]
9. [Nitric oxide and endothelins in pulmonary hypertension].
Aoki Y; Saji T
Nihon Rinsho; 2001 Jun; 59(6):1059-64. PubMed ID: 11411113
[TBL] [Abstract][Full Text] [Related]
10. [Intracellular signal transduction induced by endothelin].
Kai H; Kanaide H
Tanpakushitsu Kakusan Koso; 1991 Nov; 36(14):2372-80. PubMed ID: 1663636
[No Abstract] [Full Text] [Related]
11. Sarcoidosis-associated pulmonary hypertension: a role for endothelin receptor antagonists?
Pitsiou GG; Spyratos D; Kioumis I; Boutou AK; Nakou C; Stanopoulos I
Ther Adv Respir Dis; 2009 Jun; 3(3):99-101. PubMed ID: 19638368
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension.
Chen CH; Chen HA; Yang KY; Yu WC; Liao HT; Huang DF
Scand J Rheumatol; 2006; 35(3):245-7. PubMed ID: 16766376
[No Abstract] [Full Text] [Related]
13. [Endothelin receptor antagonist bosentan. Breakthrough in the treatment of pulmonary hypertension].
MMW Fortschr Med; 2004 Dec; 146(50):72-3. PubMed ID: 15666438
[No Abstract] [Full Text] [Related]
14. Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.
Abman SH
Annu Rev Med; 2009; 60():13-23. PubMed ID: 18764741
[TBL] [Abstract][Full Text] [Related]
15. Endothelin XII.
Barton M; Yanagisawa M; Vanhoutte PM; Masaki T
Life Sci; 2012 Oct; 91(13-14):449-51. PubMed ID: 22842029
[TBL] [Abstract][Full Text] [Related]
16. [Young patient with stress dyspnea of uncertain origin. Evaluate for pulmonary hypertension!].
MMW Fortschr Med; 2002 Oct; 144(42):64. PubMed ID: 12534004
[No Abstract] [Full Text] [Related]
17. [Dyspnea. When is it pulmonary hypertension?].
MMW Fortschr Med; 2003 Aug; 145(33-34):62. PubMed ID: 14526588
[No Abstract] [Full Text] [Related]
18. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist.
Clozel M; Breu V; Burri K; Cassal JM; Fischli W; Gray GA; Hirth G; Löffler BM; Müller M; Neidhart W
Nature; 1993 Oct; 365(6448):759-61. PubMed ID: 8413655
[TBL] [Abstract][Full Text] [Related]
20. Dual endothelin receptor antagonism in pulmonary arterial hypertension.
Pittrow D; Kirch W
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():v-vi. PubMed ID: 16919003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
